…Born in Bologna, Italy, Cristina graduated Summa Cum Laude from the University of Bologna, and completed her medical training in New York and California—including an Internal Medicine residency at Long Island College Hospital and a Cardiology fellowship at the VA/UCLA. She is board-certified in Internal Medicine, Cardiovascular Diseases, and Nuclear Cardiology, and currently serves as Chief Medical Officer and co-founder of Genescient, a biotech company dedicated to genetic research on aging and longevity.

Cristina’s journey from practicing medicine to writing thrillers reflects her resilience, intellectual curiosity, and passion for storytelling. Her debut novel, Dissection, was praised by Lee Child as “high stakes and breathless suspense,” and by Tess Gerritsen as “moving at a frantic pace.” It became a #1 Amazon bestseller in multiple categories:

• #1 in Political Thriller and Suspense (Amazon US)
• #2 in Medical Thrillers (Amazon US)
• #1 in Spy Thrillers (Amazon Canada)
• #6 in Medical Thrillers (Amazon Australia)
• #2 in Political Thrillers (Amazon UK)

Her highly anticipated sequel, Change of Heart, was released on February 4, 2025, and received acclaim from bestselling author Tess Gerritsen:

“Once again, Cristina LePort pens an excellent thriller, enlivened with vivid medical details and startling twists. She gets better with every novel!”

Dr. LePort lives in Corona del Mar, Southern California, with her husband, Peter. They are proud parents of three children and grandparents of three. When she’s not writing or researching, Cristina continues to explore the frontiers of medicine, longevity science, and literary suspense.

Website